Literature DB >> 21263932

The infectious complications of blood transfusion.

N A Buskard.   

Abstract

Infection after blood transfusion has become a major area of concern over the past decade. With current donor-screening procedures and laboratory testing of all blood donations, the chance of developing a post-transfusion infection is remote. Concern about viral infections predominates, and non-A, non-B hepatitis remains the most common form of post-transfusion viral infection. Hbv infections are unusual: the development of AIDS after a blood transfusion has been markedly reduced with rigorous donor screening and laboratory testing. At the time of writing, over six million units of blood and blood products which have been screened and tested for anti-HIV have been given to Canadians without evidence of seroconversion.

Entities:  

Year:  1987        PMID: 21263932      PMCID: PMC2218498     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  10 in total

1.  A comparison of four commercial test kits for detection of cytomegalovirus antibodies in blood donors.

Authors:  C S Feng; I B Williams; R S Gohd; A P Causey
Journal:  Transfusion       Date:  1986 Mar-Apr       Impact factor: 3.157

2.  Inactivation of the AIDS-causing retrovirus and other human viruses in antihemophilic plasma protein preparations by pasteurization.

Authors:  J Hilfenhaus; A Herrmann; R Mauler; A M Prince
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

3.  Bacterial proliferation in platelet concentrates.

Authors:  J M Heal; S Singal; E Sardisco; T Mayer
Journal:  Transfusion       Date:  1986 Jul-Aug       Impact factor: 3.157

4.  Factor VIII degradation products in heated concentrates.

Authors:  T W Barrowcliffe; S J Edwards; G Kemball-Cook; D P Thomas
Journal:  Lancet       Date:  1986-06-21       Impact factor: 79.321

5.  Screening for antibodies to LAV/HTLV-III in recipients of immunoglobulin preparations.

Authors: 
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

6.  Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.

Authors:  D E Koziol; P V Holland; D W Alling; J C Melpolder; R E Solomon; R H Purcell; L M Hudson; F J Shoup; H Krakauer; H J Alter
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

7.  Relative specificity of enzyme-linked immunosorbent assays for antibodies to human T-cell lymphotrophic virus, type III, and their relationship to Western blotting.

Authors:  C T Fang; F Darr; S Kleinman; R H Wehling; R Y Dodd
Journal:  Transfusion       Date:  1986 Mar-Apr       Impact factor: 3.157

8.  Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons.

Authors:  K C Anderson; B C Gorgone; R G Marlink; R Ferriani; M E Essex; P M Benz; J E Groopman
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

9.  Evaluation of a confidential method of excluding blood donors exposed to human immunodeficiency virus.

Authors:  J Nusbacher; J Chiavetta; R Naiman; B Buchner; V Scalia; R Herst
Journal:  Transfusion       Date:  1986 Nov-Dec       Impact factor: 3.157

Review 10.  The epidemiology and prevention of the acquired immunodeficiency syndrome.

Authors:  J W Curran
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

  10 in total
  1 in total

1.  A Critical Look at HIV-Antibody Tests: 1. How Accurate Are They?

Authors:  J W Frank; V Goel; B J Harvey; R A Coates; V Schiralli
Journal:  Can Fam Physician       Date:  1987-09       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.